Nektar Therapeutics (NKTR) Interest Coverage Ratio: History & Chart

Nektar Therapeutics(NKTR)

Biotechnology · San Francisco, CA

$40.12-2.10 (-4.97%)

Delayed quote: Oct 6, 2026, 12:25 PM EDT

About Nektar Therapeutics

Nektar Therapeutics is a biopharmaceutical firm dedicated to the global discovery and advancement of therapies addressing significant unmet medical requirements. Central to its robust pipeline is Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist. This drug is currently in Phase 3 clinical trials for metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, head and neck squamous cell carcinoma, and adjuvant melanoma. It is also being evaluated in Phase 2 for renal cell carcinoma, non-small cell lung cancer, and urothelial cancer; Phase 1/2A for head and neck squamous cell carcinoma; Phase 1/2 for various solid tumors; and Phase 1B for COVID-19. Additionally, Nektar is developing NKTR-358, a cytokine Treg stimulant, which is in Phase 2 trials for systemic lupus erythematosus and ulcerative colitis, and Phase 1B for atopic dermatitis and psoriasis. Their portfolio further includes NKTR-255, an IL-15 receptor agonist, undergoing Phase 1/2 trials for non-Hodgkin's lymphoma, multiple myeloma, head and neck cancer, and colorectal cancer. Another investigational compound, NKTR-262, a toll-like receptor agonist, is in Phase 1/2 trials for solid tumors. The company is also advancing several other drug candidates. Nektar Therapeutics maintains strategic collaboration agreements with a multitude of pharmaceutical entities, including Takeda Pharmaceutical Company Ltd., AstraZeneca AB, UCB Pharma S.A., F. Hoffmann-La Roche Ltd, Bausch Health Companies Inc., Pfizer Inc., Amgen Inc., UCB Pharma (Biogen), Bristol-Myers Squibb Company, Baxalta Incorporated, Eli Lilly and Company, Merck KGaA, and SFJ Pharmaceuticals, Inc. Established in 1990, Nektar Therapeutics is headquartered in San Francisco, California.

San Francisco, CA

63 employees

www.nektar.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Howard W. Robin

View full financials

NKTR Interest Coverage Ratio Metrics

INTEREST COVERAGE RATIO

-4.99x

INTEREST COVERAGE RATIO AVG TTM

-4.92x

INTEREST COVERAGE RATIO AVG 3Y

-6.18x

INTEREST COVERAGE RATIO AVG 5Y

-6.41x

INTEREST COVERAGE RATIO AVG 10Y

-7.26x

INTEREST COVERAGE RATIO AVG 15Y

-6.23x

INTEREST COVERAGE RATIO AVG 20Y

N/A

CURRENT VS TTM AVG

-1.51%

CURRENT VS 3Y AVG

+19.20%

CURRENT VS 5Y AVG

+22.13%

CURRENT VS 10Y AVG

+31.24%

CURRENT VS 15Y AVG

+19.92%

CURRENT VS 20Y AVG

N/A

SECTOR MEDIAN · HEALTHCARE

-5.64x

median of 469 covered companies

CURRENT VS SECTOR MEDIAN

+11.52%

vs the sector median at left

NAME	MARKET CAP	INTEREST COVERAGE RATIO	TTM	3Y	5Y
Nektar Therapeutics (NKTR)	$1.15B	-4.99x	-4.92x	-6.18x	-6.41x
GoodRx Holdings, Inc. (GDRX)vs ›	$1.15B	2.05x	1.65x	1.11x	0.98x
Avalyn Pharma Inc. Common Stock (AVLN)vs ›	$1.14B	N/A	N/A	N/A	N/A
OPKO Health, Inc. (OPK)vs ›	$1.13B	-2.02x	1.81x	1.81x	1.81x
Amphastar Pharmaceuticals, Inc. (AMPH)vs ›	$1.13B	5.51x	6.14x	19.44x	31.00x
Harrow Health, Inc. (HROW)vs ›	$1.13B	1.60x	1.00x	0.57x	0.46x
Damora Therapeutics, Inc. (DMRA)vs ›	$1.17B	N/A	N/A	N/A	N/A
Bicara Therapeutics Inc. Common Stock (BCAX)vs ›	$1.09B	N/A	N/A	N/A	N/A
Replimune Group, Inc. (REPL)vs ›	$1.09B	-36.11x	N/A	N/A	N/A
MannKind Corporation (MNKD)vs ›	$1.21B	2.81x	2.36x	1.69x	1.69x

NAME

MARKET CAP

INTEREST COVERAGE RATIO

TTM

Nektar Therapeutics (NKTR)

$1.15B

-4.99x

-4.92x

-6.18x

-6.41x

GoodRx Holdings, Inc. (GDRX)vs ›

$1.15B

2.05x

1.65x

1.11x

0.98x

Avalyn Pharma Inc. Common Stock (AVLN)vs ›

$1.14B

N/A

OPKO Health, Inc. (OPK)vs ›

$1.13B

-2.02x

1.81x

Amphastar Pharmaceuticals, Inc. (AMPH)vs ›

$1.13B

5.51x

6.14x

19.44x

31.00x

Harrow Health, Inc. (HROW)vs ›

$1.13B

1.60x

1.00x

0.57x

0.46x

Damora Therapeutics, Inc. (DMRA)vs ›

$1.17B

N/A

Bicara Therapeutics Inc. Common Stock (BCAX)vs ›

$1.09B

N/A

Replimune Group, Inc. (REPL)vs ›

$1.09B

-36.11x

N/A

MannKind Corporation (MNKD)vs ›

$1.21B

2.81x

2.36x

1.69x

Interest Coverage Ratio FAQ

What is the interest coverage ratio for Nektar Therapeutics (NKTR)?

The interest coverage ratio for NKTR stock is -4.99x.

Is Nektar Therapeutics's interest coverage ratio high or low?

The interest coverage ratio of -4.99x is 22% above its 5-year average of -6.41x, near the high end of its 5-year range (-21.03x–1.41x).

What is the TTM average interest coverage ratio for Nektar Therapeutics (NKTR)?

The TTM average interest coverage ratio for NKTR stock is -4.92x.

What is the 3Y average interest coverage ratio for Nektar Therapeutics (NKTR)?

The 3Y average interest coverage ratio for NKTR stock is -6.18x.

What is the 5Y average interest coverage ratio for Nektar Therapeutics (NKTR)?

The 5Y average interest coverage ratio for NKTR stock is -6.41x.

What is the 10Y average interest coverage ratio for Nektar Therapeutics (NKTR)?

The 10Y average interest coverage ratio for NKTR stock is -7.26x.

What is the 15Y average interest coverage ratio for Nektar Therapeutics (NKTR)?

The 15Y average interest coverage ratio for NKTR stock is -6.23x.

DATE	INTEREST COVERAGE RATIO
2026-06-30	-5.88x
2026-03-31	-4.82x
2025-12-31	-1.95x
2025-09-30	-5.21x
2025-06-30	-6.72x
2025-03-31	-8.95x
2024-12-31	1.41x
2024-09-30	-5.71x
2024-06-30	-7.77x
2024-03-31	-6.41x
2023-12-31	-4.88x
2023-09-30	-7.59x
2023-06-30	-8.22x
2023-03-31	-21.03x
2022-12-31	-5.68x
2022-09-30	-5.39x
2022-06-30	-6.47x
2022-03-31	-15.29x
2021-12-31	-13.89x
2021-09-30	-8.87x
2021-06-30	-8.42x
2021-03-31	-8.23x
2020-12-31	-13.53x
2020-09-30	-12.23x
2020-06-30	-10.59x
2020-03-31	-6.71x
2019-12-31	-8.69x
2019-09-30	-8.79x
2019-06-30	-9.90x
2019-03-31	-10.69x
2018-12-31	-8.50x
2018-09-30	-9.62x
2018-06-30	93.98x
2018-03-31	-8.37x
2017-12-31	-2.19x
2017-09-30	6.94x
2017-06-30	-5.05x
2017-03-31	-5.47x
2016-12-31	-3.11x
2016-09-30	-3.13x
2016-06-30	-3.61x
2016-03-31	-0.88x
2015-12-31	-2.67x
2015-09-30	0.04x
2015-06-30	-4.69x
2015-03-31	4.67x
2014-12-31	-3.90x
2014-09-30	8.37x
2014-06-30	-2.38x
2014-03-31	-3.67x
2013-12-31	-3.51x
2013-09-30	-0.64x
2013-06-30	-3.22x
2013-03-31	-4.46x
2012-12-31	-4.30x
2012-09-30	-2.94x
2012-06-30	-3.40x
2012-03-31	-8.75x
2011-12-31	-13.65x
2011-09-30	-8.39x
2011-06-30	-13.33x
2011-03-31	-13.10x
2010-12-31	-8.26x
2010-09-30	-2.20x
2010-06-30	0.64x
2010-03-31	-1.14x
2009-12-31	-1.85x
2009-09-30	-9.86x
2009-06-30	-10.34x
2009-03-31	-9.08x

DATE

INTEREST COVERAGE RATIO

2026-06-30

-5.88x

2026-03-31

-4.82x

2025-12-31

-1.95x

2025-09-30

-5.21x

2025-06-30

-6.72x

2025-03-31

-8.95x

2024-12-31

1.41x

2024-09-30

-5.71x

2024-06-30

-7.77x

2024-03-31

-6.41x

2023-12-31

-4.88x

2023-09-30

-7.59x

2023-06-30

-8.22x

2023-03-31

-21.03x

2022-12-31

-5.68x

2022-09-30

-5.39x

2022-06-30

-6.47x

2022-03-31

-15.29x

2021-12-31

-13.89x

2021-09-30

-8.87x

2021-06-30

-8.42x

2021-03-31

-8.23x

2020-12-31

-13.53x

2020-09-30

-12.23x

2020-06-30

-10.59x

2020-03-31

-6.71x

2019-12-31

-8.69x

2019-09-30

-8.79x

2019-06-30

-9.90x

2019-03-31

-10.69x

2018-12-31

-8.50x

2018-09-30

-9.62x

2018-06-30

93.98x

2018-03-31

-8.37x

2017-12-31

-2.19x

2017-09-30

6.94x

2017-06-30

-5.05x

2017-03-31

-5.47x

2016-12-31

-3.11x

2016-09-30

-3.13x

2016-06-30

-3.61x

2016-03-31

-0.88x

2015-12-31

-2.67x

2015-09-30

0.04x

2015-06-30

-4.69x

2015-03-31

4.67x

2014-12-31

-3.90x

2014-09-30

8.37x

2014-06-30

-2.38x

2014-03-31

-3.67x

2013-12-31

-3.51x

2013-09-30

-0.64x

2013-06-30

-3.22x

2013-03-31

-4.46x

2012-12-31

-4.30x

2012-09-30

-2.94x

2012-06-30

-3.40x

2012-03-31

-8.75x

2011-12-31

-13.65x

2011-09-30

-8.39x

2011-06-30

-13.33x

2011-03-31

-13.10x

2010-12-31

-8.26x

2010-09-30

-2.20x

2010-06-30

0.64x

2010-03-31

-1.14x

2009-12-31

-1.85x

2009-09-30

-9.86x

2009-06-30

-10.34x

2009-03-31

-9.08x

Interest Coverage Ratio: -4.99x

NKTR Interest Coverage Ratio

NKTR Average Interest Coverage Ratio Chart

NKTR Current vs Average Interest Coverage Ratio Chart

NKTR Interest Coverage Ratio Metrics

NKTR Competitors' Interest Coverage Ratio

Financial Health Indicators

Interest Coverage Ratio Formula & Definition

Interest Coverage Ratio FAQ

NKTR Interest Coverage Ratio History

Related Metrics